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ABSTRACT	
Rationale:	Lung	cancer	screening	has	the	potential	to	save	lives,	but	also	carries	risk	of	
potential	harms.	Explaining	the	benefits	and	harms	of	screening	in	a	way	that	is	balanced	
and	comprehensible	to	those	with	varying	education	is	essential.	Although	a	shared	
decision-making	approach	is	mandated	by	the	Centers	for	Medicare	and	Medicaid,	there	
have	been	no	randomized	studies	to	evaluate	the	impact	of	different	forms	of	lung	
screening	information.		
	
Objectives:	To	evaluate	the	impact	of	a	novel	information	film	on	informed	decision-making	
in	individuals	considering	participating	in	lung	cancer	screening.		
	
Methods:	A	sub-set	of	participants	from	the	Lung	Screen	Uptake	Trial	were	randomly	
allocated	either	to	view	the	information	film	and	receive	a	written	information	booklet	or	to	
receive	the	booklet	alone.	The	primary	outcome	was	objective	knowledge	score	post-
intervention.	Secondary	outcomes	included	subjective	knowledge,	decisional	conflict,	final	
screening	participation	and	acceptability	of	the	materials.	Univariate	and	multivariate	
analyses	were	carried	out	to	determine	differences	in	pre-	and	post-intervention	knowledge	
scores	in	both	groups	and	between	groups	for	the	primary	and	secondary	outcomes.	
	
Results:	In	the	final	analysis	of	229	participants,	both	groups	showed	significantly	improved	
subjective	and	objective	knowledge	scores	post-intervention.	This	improvement	was	
greatest	in	the	film	+	booklet	group,	where	mean	objective	knowledge	improved	by	2.16	
points	(SD	1.8)	in	the	film	+	booklet	group	compared	with	1.84	points	(SD	1.9)	in	the	booklet	
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alone	group	(β	coefficient	0.62,	CI	0.17-1.08,	p=0.007	in	the	multivariable	analysis).	Mean	
subjective	knowledge	increased	by	0.92	points	(SD	1.0)	in	the	film	+	booklet	group	and	0.55	
points	(SD	1.1)	in	the	booklet	alone	group	(β	coefficient	0.32,	CI	0.05-0.58,	p=0.02	in	the	
multivariable	analysis).	Decisional	certainty	was	higher	in	the	film	+	booklet	(mean	8.5/9	
points	[SD	1.3],	group	than	the	booklet	alone	group		(mean	8.2/9	points	[SD	1.5]).	Both	
information	materials	were	well	accepted,	and	there	were	no	differences	in	final	screening	
participation	rates	between	groups.		
	
Conclusions:	The	information	film	improved	knowledge	and	reduced	decisional	conflict	
without	affecting	lung	screening	uptake.	
	
This	article	has	an	online	supplement,	which	is	accessible	from	this	issue's	table	of	contents	
online	at	www.atsjournals.org	
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Impact	of	a	lung	cancer	screening	information	film	on	informed	
decision-making	-	a	randomized	trial	
INTRODUCTION	
Lung	cancer	screening	(LCS)	using	low	dose	computed	tomography	(LDCT)	has	the	
potential	to	save	lives,	though	also	carries	potential	for	harm.	There	is	evidence	that	
people	want	to	be	made	aware	of	these	harms	and	value	the	opportunity	to	make	an	
informed	decision	(1,	2).	However,	the	harms	and	benefits	of	cancer	screening	are	
often	poorly	understood	(1,	2).		They	are	also	challenging	to	communicate;	an	issue	
exacerbated	for	those	with	lower	levels	of	literacy,	who	are	likely	to	be	
overrepresented	among	the	LDCT-eligible	population,	given	the	higher	incidence	of	
lung	cancer	within	lower	socioeconomic	status	(SES)	communities	(3,	4).		Indeed,	
research	suggests	that	high	information	burden	could	actually	disengage	individuals	
with	lower	health	literacy	from	taking	part	in	screening	(5).		This	is	important	when	
considering	that	only	1.9%	of	those	eligible	are	estimated	to	have	received	a	LDCT	
screen	in	the	US	(6).		
	
The	use	of	illustrative	materials	is	associated	with	improved	understanding	and	
knowledge	around	risk	perception	(7).	Graphics	and	animation	are	known	to	enhance	
knowledge	and	recall	of	facts	related	to	specific	health	care	interventions	(8,	9).	
Several	randomized	studies	evaluating	the	use	of	‘educational	videos’	in	different	
health	care	settings	have	found	video	an	effective	medium	for	enhancing	knowledge	
and	understanding,	without	increasing	anxiety	or	decisional	conflict	(10–15).		
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A	shared	decision-making	process	is	mandated	for	LCS	reimbursement	by	the	Centers	
for	Medicare	and	Medicaid	Services	(16),	but	few	decision	tools	exist.	Lau	et	al	found	
that	a	web-based	interactive	decision	tool	significantly	increased	knowledge	and	
reduced	decisional	conflict	among	smokers	and	former	smokers	considering	
participation	in	LCS;	however,	as	the	authors	acknowledged,	web-based	access	may	
not	be	equitable	(17).	Mazzone	et	al	tested	the	impact	of	a	shared	decision-making	
visit	comprising	of	a	slide	presentation	about	the	benefits	and	harms,	use	of	the	above	
described	web-based	tool,	and	the	opportunity	for	having	questions	answered	by	a	
health	provider.	The	authors	demonstrated	a	significant	improvement	in	knowledge	
which	partially	persisted	one	month	later	(18).	Two	uncontrolled	studies	evaluated	the	
impact	of	video	(19,	20).	Volk	et	al,	developed	a	film	and	tested	it	with	52	participants	
in	a	tobacco	treatment	program	noting	high	acceptability,	improved	knowledge	scores,	
and	high	level	of	interest	in	LCS;	though	patient	demographics	and	screening	
attendance	data	were	not	provided	(19).	Reuland	and	colleagues	also	reported	an	
improvement	in	knowledge	with	use	of	a	film,	in	a	single	group	of	50	participants.	(20).		
	
Here	we	present	a	randomized	controlled	study	designed	to	understand	the	impact	of	
an	information	film	on	decision-making	and	subsequent	uptake	of	LDCT.	Validation	of	
such	a	tool	could	endorse	its	use	in	LCS.	The	information	materials	were	designed	to	
provide	basic,	standardized	information	on	LCS	and	its	harms	and	benefits	(see	Video,	
Supplemental	data	11),	and	to	be	supplemented	with	a	health	care	professional	(HCP)	
discussion	to	support	the	decision-making	process.	We	tested	whether	the	film	plus	
information	booklet	enhanced	objective	and	subjective	knowledge	over	the	booklet	
																																																						
1	Also	available	at	https://www.roycastle.org/lungcancerscreeningguide	
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alone.	We	also	evaluated	additional	impact	on	decisional	conflict	and	uptake	of	LDCT,	
and	assessed	acceptability	of	both	the	booklet	and	film.	
	
METHODS		
Participants	and	setting	
This	is	a	nested	randomized	study	within	the	Lung	Screen	Uptake	Trial	(LSUT),	the	
methods	for	which,	have	been	previously	described	(21).	Briefly,	LSUT	invited	smokers	
and	former	smokers	(within	5	years	of	quitting)	aged	60-75,	identified	from	primary	
care	records,	to	a	‘lung	health	check’	(LHC)	at	a	local	London	hospital	using	one	of	two	
sets	of	randomly	allocated	invitation	materials.	The	primary	aim	of	LSUT	was	to	
compare	differences	in	uptake	to	the	LHC	(where	LDCT	is	offered)	between	the	two	
invitation	materials.	Those	who	attended	the	LHC	were	invited	to	be	enrolled	in	LSUT	
and	offered	an	LDCT	if	meeting	any	of	the	following	three	criteria	and	with	no	physical	
contra-indication	to	LDCT	scanning:		
• Meeting	the	US	Preventative	Services	Task	Force	recommendation	(USPSTF)	
(22),	i.e.	≥30	pack-year	smoking	history	and	quit	<15	years	ago	
• ≥1.51%	6-year	lung	cancer	risk	as	per	the	PLCOm2012	model	(23)	
• ≥2.5%		5-year	lung	cancer	risk	as	per	the	of	LLPv2	model	(24)	
	
Between	August	2016	and	February	2017,	LSUT	enrollees	were	also	invited	to	
participate	in	the	current	study.	
	 9	
Study	design	&	interventions	
Following	informed	consent,	participants	underwent	simple	parallel	randomization	
without	restriction,	with	1:1	individual	allocation	to	each	group.	Randomization	was	
carried	out	by	the	HCP	via	a	computer	based	randomization	system.	
	
Those	randomized	to	the	control	group	received	the	information	booklet		(see	Figure	
S1,	Supplemental	data	2)	used	for	LSUT’s	control	invitation	materials	(21).	Those	
randomized	to	the	intervention	group	were	shown	an	information	film	and	given	the	
same	information	booklet.	The	film	(see	Video,	Supplemental	data	12)	content	and	
format	was	developed	using	data	from	our	qualitative	work	with	screening-eligible	
participants	and	HCPs.	Both	interventions	discussed	lung	cancer,	the	benefits	and	
harms	of	LCS	(including	indeterminate	pulmonary	nodules	and	false	positives,	
overdiagnosis	and	radiation	damage),	the	LDCT	procedure	and	the	possible	results	
following	the	scan.		The	booklet	was	ten	pages	long	and	designed	to	be	clear	and	
comprehensible	for	those	with	a	reading	age	of	11-13	years.	The	film	was	five	and	a	
half	minutes	long.	
	
Participants	were	allocated	ten	minutes	to	read	the	booklet	and/or	watch	the	film	in	
the	presence	of	one	of	eight	HCPs	involved	in	the	data	collection	for	this	study.	HCPs	
were	nurses	or	clinical	trials	practitioners	who	had	been	specifically	trained	in	the	
consent	process.	Following	a	further	knowledge	assessment	as	described	below,	
demographic,	smoking	and	medical	history	data	were	collected	to	assess	lung	cancer	
risk	and	eligibility	for	LDCT.	Participants	were	subsequently	informed	of	elevated	lung	
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cancer	risk	(if	applicable)	when	compared	to	the	general	population	and	thus	eligibility	
to	LDCT,	and	prompted	to	ask	any	questions	about	the	harms	and	benefits.	At	this	
point,	if	happy	to	proceed,	written	consent	to	undergo	the	LDCT	was	taken	by	the	HCP,	
once	again	naming	the	potential	harms	of	LDCT	as	per	a	‘consent	checklist’	(see	Figure	
S2,	Supplemental	data	2).		
	
Outcome	measures		
The	primary	endpoint	was	a	post-intervention	10-point	objective	knowledge	score	that	
assessed	facts	relating	to	the	benefits	and	harms	of	LCS	contained	in	both	intervention	
materials	(see	Table	S1,	Supplemental	data	2).	For	the	objective	knowledge	questions,	
a	‘not	sure’	or	incorrect	answer	were	treated	the	same	and	not	awarded	any	points,	
while	only	the	correct	answer	received	a	score	of	one.		
	
Secondary	endpoints	included	a	5-point	subjective	investigator-designed	knowledge	
assessment,	adapted	measures	from	the	low	literacy	decisional	conflict	scale	(DCS)	
(25))	(see	Table	S1,	Supplemental	data	2),	LDCT	completion	and	feedback	on	the	
information	materials.	For	the	subjective	questions	a	‘yes’	response	received	one	
point,	while	a	‘no’	or	‘not	sure’	received	no	points.	Yes/no	responses	to	the	DCS	
questions	were	scored	one	point	for	‘yes’	and	zero	for	‘no’.	Subjective	and	objective	
knowledge	assessments	(using	the	same	questions)	were	carried	out	at	baseline	and	
immediately	post	intervention	for	both	groups	and	other	secondary	outcomes	were	
assessed	at	the	end	of	the	consultation	with	the	HCP.		
	
Medical	and	smoking	history	and	demographic	data	were	also	collected.	This	included	
collection	of	address	postal	codes,	to	categorize	Index	of	Multiple	Deprivation	(IMD)	
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score.	This	is	an	“official	measure	of	relative	deprivation	for	small	areas	(or	
neighbourhoods)	in	England”	and	covers	the	following	domains:	income,	employment,	
health	deprivation	and	disability,	education	skills	and	training,	barriers	to	housing	and	
services,	crime	and	living	environment	(26).	
	
Sample	size	&	statistical	analysis		
Three	well	designed	studies	using	video	decision	aids,	report	intervention-related	
improvements	in	knowledge	scores	by	24%	(27),	21%	(28)	and	78%	(19).	Other	studies	
have	failed	to	detect	a	significant	effect,	however,	these	were	heavily	underpowered.	
For	the	present	study,	a	sample	size	of	210	participants	was	calculated	to	confer	96%	
power	to	detect	as	significant	a	mean	difference	of	1.0	between	the	knowledge	scores	
of	the	groups,	anticipating	a	mean	score	of	4	in	the	booklet	only	group	and	5	in	the	
booklet	plus	film	group,	with	a	standard	deviation	(SD)	of	1.9	(2-sided	testing	at	5%	
significance	level).	
	
Descriptive	statistics	were	used	to	illustrate	the	demographic	characteristics	of	both	
groups	and	the	acceptability	data.	Because	we	used	both	non-parametric	and	
parametric	inferential	analyses,	we	reported	both	means	and	medians.		Noting	that	
the	scores	were	not	normally	distributed,	univariate	analyses	using	the	Wilcoxon	
signed	rank	test	were	used	to	compare	the	primary	outcome	knowledge	scores	pre-	
and	post-intervention.	Observations	with	missing	values	were	excluded	from	the	
analysis.	Multivariable	analyses,	using	multiple	linear	regression	(which	assumes	that	
residuals,	not	the	raw	scores,	are	normally	distributed),	adjusting	for	baseline	scores,	
age,	educational	level,	ethnicity,	IMD	score	and	smoking	duration	(as	these	were	
factors	with	clinical	and/or	statistical	relevance),	were	used	to	assess	between-trial	
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arm	differences	in	overall	knowledge	scores.	Risk	ratios	were	also	used	to	assess	group	
differences	between	individual	items	for	knowledge,	DCS	and	uptake	to	LDCT	between	
the	groups.	Analyses	were	carried	out	using	STATA	v13	&	v14.	
	
Ethics	
This	study	was	part	of	the	LSUT,	which	has	had	ethical	approvals	granted	by	the	City	
Road	and	Hampstead	NHS	Research	Ethics	Committee	(REC;	reference:	15/LO/1186).	
LSUT	has	been	registered	by	clinicaltrials.gov	(NCT02558101)	and	the	International	
Standard	Registered	Clinical/social	sTudy	Number	(ISRCTN21774741).		
	
RESULTS	
252	LSUT	participants	were	invited	to	take	part	in	the	present	trial.	246	participants	
agreed	to	participate	and	were	randomized.	17	participants	had	incomplete	baseline	
data	and	so	229	participants	were	included	in	the	final	analysis	(figure	1).	The	
demographics	of	the	study	participants	are	reported	in	table	1.		
	
Total	knowledge	scores	
There	was	an	increase	in	objective	knowledge	scores	following	exposure	to	the	
information	materials	in	both	groups,	with	a	change	in	median	scores	from	5/10	to	
8/10,	and	5/10	to	7/10	in	the	film	+	booklet	and	booklet	alone	groups	respectively	
(both	p<0.001).	Mean	objective	knowledge	scores	increased	by	2.16	(SD	1.8)	and	1.84	
(SD	1.9)	in	the	film	+	booklet	and	booklet	alone	groups	respectively.	There	was	also	an	
increase	in	subjective	knowledge	scores	in	both	groups	(change	in	median	scores	from	
4/5	to	5/5	in	both	groups,	p<0.001)	(figure	2).	Mean	subjective	knowledge	increased	
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by	0.92	(SD	1.0)	and	0.55	(SD	1.1)	in	the	film	+	booklet	and	booklet	alone	groups	
respectively.	
	
In	multivariable	analyses	adjusted	for	age,	education,	ethnicity,	years	smoked	and	
index	of	multiple	deprivation	(IMD)	score,	the	greater	increases	in	the	film	group	in	
objective	and	subjective	knowledge	scores	remained	significant		(β	coefficient	0.62,	CI	
0.17-1.08,	p=0.007	and	β	coefficient	0.32,	CI	0.05-0.58,	p=0.02	respectively)		(see	
Figure	2).	Recognizing	the	fact	that	32	subjects	had	missing	IMD	score,	and	that	the	
data	were	not	normally	distributed,	we	also	carried	out	quantile	(median)	regressions	
with	multiple	imputation	for	IMD.	Results	were	largely	unchanged,	with	the	film	group	
showing	significantly	higher	changes	to	both	objective	and	subjective	knowledge	
scores	(details	available	from	the	authors).	
	
Because	the	study	was	nested	in	the	wider	randomized	trial,	half	the	participants	in	
both	groups	(randomly	allocated)	would	have	seen	the	control	information	booklet	
prior	to	arriving	at	the	LHC.	A	sensitivity	analysis	was	therefore	carried	out	by	
repeating	the	multivariable	analysis	adjusting	for	exposure	to	the	control	booklet	prior	
to	the	LHC.	This	revealed	that	prior	exposure	to	the	information	booklet	did	not	have	
significant	impact	on	knowledge	scores,	objective	(p=0.33)	and	subjective	(p=0.11).	
	
Individual	knowledge	items	
Of	all	the	individual	items	in	the	subjective	and	objective	knowledge	questionnaires,	
only	two	items	from	the	objective	knowledge	questions	showed	any	statistically	
significant	difference	between	the	two	groups.	These	two	items	showed	a	higher	risk	
ratio	for	participants	to	improve	their	response	from	incorrect	to	correct	in	the	film	+	
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booklet	group	compared	with	the	booklet	alone	group.	The	two	significant	items	were	
the	understanding	that	an	‘unclear’	result	at	screening	(i.e.	an	indeterminate	
pulmonary	nodule)	did	not	mean	a	high	risk	of	cancer	(RR	1.51,	CI	1.07	–	2.13),	and	
that	the	amount	of	radiation	in	an	LDCT	scan	is	equivalent	to	one	year	of	background	
radiation	in	the	UK	(RR	1.52,	CI	1.03–	2.25)	(Table	S2,	Supplemental	data	2).		
	
Decisional	conflict	
The	adapted	low	literacy	DCS	score	was	high	(reflecting	low	decisional	conflict)	in	both	
groups	with	a	median	of	9/9	(IQR	9,9)	and	mean	of	8.5	(SD	1.25)	in	the	film	+	booklet	
group;	and	a	median	of	9/9	(IQR	8,9)	and	mean	of	8.24	(SD	1.49)	in	the	booklet	alone	
group	(see	Figure	S3,	Supplemental	data	2).	The	film	+	booklet	group	had	higher	
adapted	DCS	than	the	booklet	alone	group	in	the	adjusted	multivariable	analysis	
(p=0.007)	reflecting	greater	decision	certainty	in	the	film	+	booklet	group.	A	
Cronbach’s	test	for	internal	validity	of	the	adapted	scale	showed	acceptable	internal	
consistency	(α=0.78).		
	
LDCT	completion	
LDCT	completion	rates	did	not	significantly	differ	across	groups	(p=0.66),	with	76.7%	
and	78.9%	proceeding	to	LDCT	in	the	film	+	booklet	and	booklet	groups	respectively.	
	
Feedback	and	acceptability	of	the	information	materials	
The	film	and	information	booklet	were	both	well	accepted	and	felt	to	be	useful,	
comprehensible	and	contain	the	correct	level	of	information,	though	more	participants	
watched	the	entire	film	than	read	the	entire	booklet	(100%	vs.	62%,	p<0.001),	and	
understood	all	or	most	of	the	film	than	booklet	(96.5%	vs.	85.9%,	p<0.001)	(figure	3).	
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The	film	group	participants	were	asked	for	additional	feedback,	and	68.7%	felt	the	film	
to	be	memorable,	64.3%	found	the	film	helpful	for	their	decision-making	and	79.4%	
would	have	watched	the	film	if	it	had	been	available	to	them	before	the	LHC.	In	
addition,	59.8%	described	the	film	as	‘completely	balanced’,	while	23.2%	described	it	
as	‘clearly	slanted	towards	screening’.	
	
DISCUSSION	
We	report	the	findings	of	a	randomized	study	evaluating	the	impact	of	a	novel	decision	
tool	on	IDM	in	LCS.	In	this	nested	study	of	229	participants	from	a	larger	cohort	of	
individuals	invited	to	an	LHC	by	their	GP	and	participating	in	LSUT,	an	information	film	
plus	written	information	booklet	improved	objective	and	subjective	knowledge,	and	
reduced	decisional	conflict	more	than	the	booklet	alone,	with	no	significant	impact	on	
numbers	of	individuals	subsequently	completing	a	LDCT	examination;	both	
information	materials	were	well	received.		
	
Our	findings	that	baseline	objective	knowledge	was	poor	(median	5/10)	is	in	keeping	
with	other	studies	(2,	20),	while	subjective	knowledge	was	better	(median	3/5)	
suggesting	that	individuals’	perception	of	their	knowledge	about	LCS	may	be	
somewhat	optimistic.	The	changes	in	the	mean	scores	need	to	be	interpreted	with	
caution	given	the	discrete	rather	than	continuous	nature	of	the	scores.	Both	groups	
significantly	improved	their	knowledge	scores	after	exposure	to	the	information	
materials,	which	demonstrates	that	use	of	such	tools	enhances	understanding	of	LCS.	
This	is	supported	by	other	single	group	studies	of	decision	tools	in	LCS	(18–20,	29),	
though	a	reduction	in	knowledge	at	one	month	has	been	reported	(18),	thereby	
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emphasizing	the	need	to	repeat	the	‘informing’	process	at	repeat	screening	visits.	Our	
findings,	particularly	the	comparison	of	the	randomized	arms,	support	the	use	of	the	
film,	which	contained	graphics	and	animation	as	an	engaging	and	effective	means	to	
enhance	understanding.	The	film	was	designed	to	be	used	as	an	adjunct	to	an	HCP	
consultation,	whose	role	in	shared	decision-making	is	vital.	Most	conventional	LCS	
information	materials	are	written,	but	reliance	on	written	communication	materials	
have	been	noted	to	be	problematic	(5,	30).		Web-based	tools	can	be	effective	and	
personalized	to	the	individuals’	needs	but	may	be	less	accessible	to	older	or	lower	SES	
populations	who	are	the	target	for	LCS.	This	study	has	shown	a	significant	impact	of	
the	information	film	over	the	booklet	alone	on	knowledge	and	decisional	conflict,	in	a	
population	that	was	eligible	for	LDCT	screening	and	faced	with	the	decision	about	
undertaking	an	LDCT.	This	makes	the	results	directly	generalizable	to	the	target	
population.	
	
The	film	had	a	greater	impact	than	the	booklet	on	two	aspects	of	specific	knowledge:	
the	significance	of	radiation	exposure	from	LDCT	and	the	fact	that	an	‘unclear’	result	
(signifying	an	indeterminate	pulmonary	nodule)	carries	a	low	overall	risk	of	
malignancy.	This	is	of	value,	as	better	understanding	of	these	concepts	may	in	turn	
have	an	impact	on	the	psychological	responses	to	LCS	and	indeterminate	(termed	false	
positives)	results	(31,	32).	Certainly,	improved	communication	has	been	reported	to	be	
associated	with	improved	adherence	to	CT	surveillance,	and	reduced	distress	in	the	
context	of	non-LCS-detected	pulmonary	nodules	(33)	and	it	is	imperative	that	we	
translate	these	findings	into	the	development	of	information	materials	in	LCS.	
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LCS	has	been	proven	to	be	an	effective	intervention	that	reduced	lung	cancer-specific	
mortality	by	20%	(34)	and	was	recommended	by	the	USPSTF	in	2013	(22).	Despite	this,	
uptake	to	LDCT	in	the	US	has	been	low	with	only	1.9%	of	the	7.6	million	eligible	
smokers	having	undergone	a	LDCT	examination	as	part	of	LCS	according	to	a	recent	
report	from	data	from	the	American	College	of	Radiology	LCS	registry	(6).	The	likely	
barriers	to	uptake	are	multifactorial	and	complex	(35).		However,	once	an	individual	is	
considering	LCS,	it	is	vital	that	we	communicate	the	benefits	and	harms	using	
information	resources	that	are	engaging	and	accessible	(i.e.	low	information	burden)	
to	individuals	with	varying	levels	of	literacy,	and	that	do	not	over-emphasize	either	the	
harms	or	benefits.	Individuals	have	been	noted	to	have	a	desire	to	hear	an	‘expert	
opinion’	(36)	or	‘clinician	guidance’	(37)	when	making	medical	and	screening-related	
decisions	and	it	is	important	that	information	materials	incorporate	such	guidance.		
	
The	data	from	our	study	show	that	the	film	was	well	received	and	generally	
participants	found	it	to	be	helpful	and	balanced,	though	a	proportion	found	it	to	be	
biased	in	favor	of	screening,	which	may	reflect	the	impressive	20%	relative	reduction	
and	the	positive	patient	testimonial	included	in	the	information	materials.	A	significant	
proportion	also	found	it	not	helpful	for	decision-making,	perhaps	in	view	of	the	
difficult	balance	of	benefits	and	harms,	however	the	low	decisional	conflict	observed	
by	the	end	of	the	consultation	suggests	people	were	ultimately	satisfied	with	their	
decision	and		reinforces	that	the	film	should	not	replace	the	HCP	discussion.	The	
ultimate	aim	for	IDM	is	for	the	individual	to	possess	the	relevant	information	on	
harms,	benefits	and	the	options	available	to	them,	and	then	to	be	able	to	process	that	
information	to	make	a	decision	that	is	in	line	with	their	personal	beliefs	and	values	
(38).	Our	aim	was	for	the	film	to	ensure	that	the	harms	were	presented	fairly	and	
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accurately,	while	still	making	the	benefits	clear.	The	film	can	aid	the	IDM	process	and	
the	HCP	can	further	help	individuals	arrive	at	an	informed	decision	where	required.			
	
An	important	point	in	this	study	is	that	participants	were	already	attending	a	LHC	and	
so	were	somewhat	engaged	with	the	screening	process.	The	findings	endorse	the	use	
of	the	film,	for	example,	to	be	played	on	a	loop	in	the	waiting	room	prior	to	the	pre-
LDCT	consultation	with	an	HCP.	Given	recent	reports	of	poor	performance	with	respect	
to	shared	decision-making	for	LCS	in	the	US	(39,	40),	this	could	be	an	important	use	for	
a	valuable	tool.		The	likely	impact	of	the	film	if	it	were	viewed	prior	to	attending	the	
LHC	or	screening	visit	was	not	tested	in	the	present	study.	Given	that	almost	no	
participants	felt	it	was	biased	against	screening,	the	film	may	not	deter	those	who	are	
inclined	to	engage	with	preventative	health	behaviors	from	taking	part	in	LCS,	however	
further	studies	in	this	context	are	required	to	understand	this.	
	
Strengths	and	Limitations	
The	information	film	is	not	a	decision	aid	as	it	does	not	meet	all	the	criteria	on	the	
International	Patient	Decision	Aid	Standards	(IPDAS)	checklist	which	is	a	detailed	list	of	
specifications	that	we	were	unable	to	comprehensively	address	in	a	short	film	(41).	
Our	intention	was	for	the	film	to	be	used	to	provide	information	that	would	facilitate	
the	HCP	in	their	discussion,	and	not	to	replace	it.	Secondly,	we	used	an	adapted	
version	of	the	low	literacy	DCS	scale	(25),	which	has	not	been	validated	but	showed	
acceptable	internal	validity.	The	impact	of	the	information	film	is	likely	to	be	
understated,	as	a	ceiling	effect	was	observed	with	both	the	DCS	and	the	subjective	
knowledge	scores.	Thirdly,	both	the	interventions	were	delivered	in	the	presence	of	a	
HCP	and	so	did	not	imitate	a	‘real-world’	setting	where	there	may	be	variability	in	the	
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amount	of	information	material	watched	or	read.	However,	some	‘real-world’	
variability	may	have	been	simulated	in	light	of	the	fact	that	consultations	were	carried	
out	by	eight	different	HCPs.	In	addition,	as	described	above	the	study	was	conducted	
in	a	group	of	individuals	already	attending	a	LHC	and	who	may	be	more	engaged	in	
preventative	health	behaviors;	nevertheless,	the	study	is	strengthened	by	the	likely	
generalizability	of	the	results	to	the	target	population.	The	study	participants	were	
invited	to	participate	using	similar	eligibility	criteria	to	those	advised	by	the	USPSTF	
(42)	and	a	number	of	other	projects	internationally	(43–46).	
	
Future	work	could	involve	testing	of	the	film	prior	to	attendance	at	an	LHC;	and	to	
assess	longer-term	knowledge	and	decisional	conflict	and	satisfaction,	as	well	assess	
the	impact	of	such	tools	on	the	psychological	morbidity	associated	with	a	diagnosis	of	
an	indeterminate	pulmonary	nodule	following	LCS.		The	research	team	have	been	
approached	by	a	number	of	centers	in	the	UK	and	US	for	use	of	the	information	film	in	
their	local	LCS	projects,	and	a	strength	of	this	medium	is	that	it	can	be	easily	adapted	
for	local	needs	and	preferences.	
	
Conclusions	
This	nested	randomized	study	has	demonstrated	that	the	developed	information	film	
has	positively	impacted	knowledge	and	decisional	conflict	more	than	the	booklet	alone	
without	reducing	uptake	of	LDCT.	We	propose	that	use	of	the	film,	as	an	adjunct	to	the	
HCP	role	in	shared	decision-making,	standardizes	and	enhances	knowledge	about	LCS	
benefits	and	harms,	and	improves	knowledge	and	decisional	conflict	associated	with	
LCS.		
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whether	or	not	to	be	screened;	d)	film	group	only:	how	balanced	they	perceived	the	film	to	be.	 	
Table	1	Participant	characteristics	by	group	
%	totals	may	not	sum	up	due	to	rounding,	or	missing	data.		
Figures	expressed	as	number	and	(%)	or	median	and	(interquartile	range).		
US	equivalent	education	levels	are:	§less	than	high	school	education;	§§high	school	graduate;	§§§Post	
high	school	training;	+Some	college;	++College	graduate;	+++	Postgraduate/	professional	
Variables	
Groups	
	n	(%)	or	median	(IQR)*	
	
Intervention,	n=120	
(Film	+	Booklet)	
Control,	n=109	
(Booklet	only)	
Age	(in	years)	
60	–	63	 40	(33.33)	 44	(40.37)	
64	–	67	 33	(27.50)	 32	(29.36)	
68	–	71	 33	(27.50)	 20	(18.35)	
72	–	76	 14	(11.67)	 13	(11.93)	
Gender	
Female	 65	(54.17)	 54	(49.54)	
Male	 54	(45.83)	 55	(50.46)	
Ethnicity	
White	 98	(81.67)	 92	(84.40)	
Black/	African/	Caribbean	 13	(10.83)	 8	(7.34)	
Asian	 3	(2.50)	 4	(3.67)	
Other	 6	(5.00)	 5	(4.59)	
Level	of	Education	
At	or	before	15§	 61	(50.83)	 52	(47.71)	
CSEs,	O-levels	or	equivalent§§	 12	(10.00)	 15	(13.76)	
A-levels	or	equivalent§§§	 20	(16.67)	 15	(13.76)	
Further	education+		 6	(5.00)	 2	(1.83)	
Bachelor	degree++		 12	(10.00)	 16	(14.68)	
Further	higher	degree+++	 8	(6.67)	 6	(5.50)	
Other		 1	(0.83)	 3	(2.75)	
Index	of	Multiple	Deprivation	(IMD)	quintile	
1	(most	deprived)	 69	(57.50)	 50	(45.87)	
2	 35	(29.17)	 37	(33.94)	
3	 3	(2.50)	 3	(2.75)	
4	 0	(0)	 0	(0)	
5	(least	deprived)	 0	(0)	 0	(0)	
Smoking	
Average	cig	smoking	(cig/day),	median	 16	(10,20)	 15	(10,20)	
Number	of	pack-years,	median	 38	(21,50)	 35	(21,51)	
Years	smoked,	median	 47	(43,52)	 46	(42,51)	
Research	Site	
University	College	Hospital	London	 45	(37.5)	 59	(54.13)	
Homerton	University	Hospital	 75	(62.5)	 50	(45.87)	
Invitation	group	(from	primary	randomization	in	LSUT)	
Group	A	 52	(43.33)	 59	(54.13)	
Group	B	 68	(56.67)	 50	(45.87)	
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Table	S1.	Outcome	measures	for	objective	and	subjective	knowledge	items	and	adapted	low	literacy	decisional	conflict	scale	
Table	S2.	Risk	ratios	(RR)	for	improving	answers	from	an	incorrect	to	correct	response	in	the	post	intervention	assessment	for	individual	objective	
and	subjective	knowledge	items	in	the	film	+	booklet	group	(reference	booklet	only	group)	
Figure	S1.	The	control	information	booklet	
Figure	S2.	The	checklist	of	points	to	be	covered	for	standardization	of	the	consent	process	
Figure	S3.	The	frequency	histograms	of	the	adapted	DCS	by	group	
This	article	also	has	an	online	video	data	supplement	(Supplementary	Appendix	1)		
Table	S1.	Outcome	measures	for	objective	and	subjective	knowledge	items	and	adapted	low	literacy	decisional	conflict	scale.	*For	the	objective	knowledge	
questions	only	the	correct	answer	was	awarded	a	point	while	incorrect	or	‘not	sure’	responses	scored	0.		**For	the	subjective	knowledge	questions,	an	answer	
of	‘yes’	was	awarded	a	point,	while	‘no’	and	‘not	sure’	scored	0.	
Objective	Knowledge	questions*:	 Response	options	
Everyone	in	the	population	has	the	same	risk	of	lung	cancer	 True/	False/	Not	sure	
Lung	cancer	screening	is	only	for	people	with	symptoms	 True/	False/	Not	sure	
All	lung	cancers	found	by	screening	will	eventually	cause	illness	and	death	if	they	are	not	treated		 True/	False/	Not	sure	
When	lung	cancer	is	picked	up	at	screening,	the	chances	of	cure	are	higher	than	without	screening	 True/	False/	Not	sure	
Lung	cancer	screening	will	pick	up	every	lung	cancer	 True/	False/	Not	sure	
If	there	is	an	unclear	result	at	screening,	the	chance	of	having	lung	cancer	is	greater	than	50%	 True/	False/	Not	sure	
The	amount	of	radiation	from	a	screening	CT	scan	is	low	and	is	similar	to	a	year’s	worth	of	radiation	from	the	natural	environment	 True/	False/	Not	sure	
All	people	with	suspected	lung	cancer	on	the	screening	CT	scan,	who	go	on	to	have	tests,	will	have	lung	cancer	 True/	False/	Not	sure	
Research	has	shown	CT	screening	for	lung	cancer	may	save	20%	more	lives	from	lung	cancer	than	chest	x-rays	 True/	False/	Not	sure	
If	100	smokers	were	screened	for	lung	cancer,	how	many	do	you	think	would	be	found	to	have	lung	cancer?	(please	write	number(	 _____________	
Subjective	Knowledge	questions**:	 	
Do	you	understand	who	could	benefit	from	lung	cancer	screening?	 Yes/	No/	Not	sure	
Do	you	know	your	level	of	risk	for	lung	cancer?	 Yes/	No/	Not	sure	
Do	you	understand	what	the	aims	of	lung	cancer	screening	are?	 Yes/	No/	Not	sure	
Do	you	understand	what	the	risks	of	lung	cancer	screening	are?		 Yes/	No/	Not	sure	
Do	you	understand	how	often	the	risks	of	lung	cancer	screening	occur?		 Yes/	No/	Not	sure	
Adapted	decisional	conflict	scale	questions:	 	
Do	you	know	the	benefits	of	lung	cancer	screening?	 Yes/	No	
Do	you	know	the	risks	and	side	effects	of	lung	cancer	screening?	 Yes/	No	
Are	you	clear	about	which	benefits	matter	most	to	you?	 Yes/	No	
Are	you	clear	about	which	risks	and	side	effects	matter	most	to	you?	 Yes/	No	
Do	you	have	enough	support	from	others	to	make	a	choice	about	whether	or	not	to	be	screened	for	lung	cancer?	 Yes/	No	
Are	you	choosing	without	pressure	from	others?	 Yes/	No	
Do	you	have	enough	advice	to	make	a	choice	about	whether	or	not	to	be	screened	for	lung	cancer?	 Yes/	No	
Are	you	clear	about	whether	being	screened	for	lung	cancer	is	the	best	choice	for	you?	 Yes/	No	
Do	you	feel	sure	about	choosing	whether	to	be	screened	or	not?	 Yes/	No	
	
	
Table	S2.		Risk	ratios	(RR)	for	improving	answers	from	an	incorrect	to	correct	response	in	the	post	intervention	assessment	for	individual	objective	and	
subjective	knowledge	items	in	the	film	+	booklet	group	(reference	booklet	only	group)*	the	numbers	represent	changing	the	correct	answer	post	into	scores	
and	not	the	absolute	number	of	correct	answers	post.		**	RR=	risk	ratio		***	if	P<0.05.	
	 	
Item	questions	 Correct	scores	post*	booklet	only,	n	(%)	
Correct	scores	post*	
booklet	+	film,	n	(%)	 RR**	(95%	CI)	 p-value	
Objective	 	 	 	 	
1.	Everyone	in	the	population	has	the	same	risk	of	lung	cancer	 17(15.60)	 9(7.50)	 0.48	(0.22-1.03)	 0.06	
2.	Lung	cancer	screening	is	only	for	people	with	symptoms	 19(17.43)	 25	(20.83)	 1.20	(0.70	–	2.04)	 0.51	
3.	All	lung	cancers	found	by	screening	will	eventually	cause	illness	and	death	if	they	are	
not	treated	 22(20.18)	 29(24.17)	 1.20	(0.73	–	1.95)	 0.47	
4.	When	lung	cancer	is	picked	up	at	screening,	the	chances	of	cure	are	higher	than	without	
screening	 7(6.42)	 9(7.50)	 1.16	(0.45	–	3.03)	 0.75	
5.	Lung	cancer	screening	will	pick	up	every	lung	cancer	 35(32.11)	 47(39.17)	 1.22	(0.86–	1.74)	 0.27	
6.	If	there	is	an	unclear	result	at	screening,	the	chance	of	having	lung	cancer	is	greater	than	
50%	 33(30.28)	 55(45.83)	 1.51	(1.07	–	2.13)	 0.02***	
7.	The	amount	of	radiation	from	a	screening	CT	scan	is	low	and	is	similar	to	a	year’s	worth	
of	radiation	from	the	natural	environment	 28(25.69)	 47(39.17)	 1.52	(1.03–	2.25)	 0.03***	
8.	All	people	with	suspected	lung	cancer	on	the	screening	CT	scan,	who	go	on	to	have	
tests,	will	have	lung	cancer	 26(23.85)	 30(25.00)	 1.05	(0.66	–	1.65)	 0.84	
9.	Research	has	shown	CT	screening	for	lung	cancer	may	save	20%	more	lives	from	lung	
cancer	than	chest	x-rays	 16(14.68)	 24(20)	 1.36	(0.77-	2.43)	 0.29	
10.		If	100	smokers	are	screened	for	lung	cancer,	how	many	do	you	think	would	be	found	
to	have	lung	cancer?	 41(37.61)	 43	(35.83)	 0.95(0.68	–	1.34)	 0.78	
Subjective	 	 	 	 	
1.	Do	you	understand	who	could	benefit	from	lung	cancer	screening?	 2(1.83)	 7(5.83)	 3.18	(0.67	–	14.98)	 0.12	
2.	Do	you	know	your	level	of	risk	for	lung	cancer?	 19(17.43)	 23(19.17)	 1.10	(0.63	–1.90)	 0.73	
3.	Do	you	understand	what	the	aims	of	lung	cancer	screening	are?	 7(6.42)	 13(10.83)	 1.69	(0.70	–	4.07)	 0.24	
4.	Do	you	understand	what	the	risks	of	lung	cancer	screening	are?	 25(22.94)	 37(30.83)	 1.34	(0.87	–	2.08)	 0.18	
5.	Do	you	understand	how	often	the	risks	of	lung	cancer	screening	occur?	 33(30.28)	 44(36.67)	 1.21	(0.84	–1.75)	 0.31	
Figure	S1.	The	control	information	booklet




	
	
Figure	S2.	The	checklist	of	points	to	be	covered	for	standardization	of	the	consent	process	
Consent	checklist	
• If	appropriate-	tell	them	they	have	a	higher	than	average	risk	of	lung	cancer	due	to	
their	age,	smoking	and	other	history	and	that	they	are	eligible	to	be	offered	a	CT	scan	
• CT	scan	is	a	3d	x-ray	test,	not	painful,	like	a	big	doughnut.	
• Takes	about	10	minutes	with	perhaps	a	little	waiting	before	hand	
• Important	to	hold	their	breath	for	a	short	time	but	they	will	be	instructed.	
• But	before	they	decide	whether	to	go	ahead,	they	should	be	aware	of	the	pros	and	
cons	and	make	their	own	mind	up	whether	its	right	for	them	to	go	ahead.		
Pros:	
• Currently	lung	cancer	is	often	diagnosed	late	due	to	symptoms	occurring	late.	With	
screening	we	aim	to	detect	lung	cancer	earlier	which	offers	a	higher	chance	of	cure.	
• A	US	study	showed	we	might	save	20%	of	lives	that	could	have	been	lost	from	lung	
cancer	if	we	screen	high-risk	individuals	
Cons:	
• Radiation-	the	amount	of	radiation	in	1	scan	is	about	the	same	as	what	you’d	get	from	
the	environment	in	a	year,	and	isn’t	too	harmful.	However	many	scans	over	a	lifetime	
especially	when	young,	can	cause	harm.	
• Indeterminate	results-	about	a	quarter	of	all	patients	undergoing	screening	will	have	a	
“spot”.	This	will	mean	the	need	for	further	tests	to	check	for	growth.	This	can	cause	
anxiety.	If	this	does	happen	to	you,	try	not	to	worry	as	about	90%	of	those	with	spots,	
will	turn	out	not	to	have	cancer.		I.e.	only	2	in	every	100	screened	will	have	cancer.	
• Overdiagnosis-	The	screening	test	may	pick	up	slow	growing	cancers	that	you	may	end	
up	having	tests	or	treatments,	when	they	may	be	so	slow	growing	that	without	the	
screening	tests	you	may	have	gone	on	another	15-20	years	without	knowing	there	
was	cancer,	and	it	may	not	cause	symptoms.	
• Very	rarely,	the	test	may	miss	small	cancers	
	
	Figure	S3.	The	frequency	histograms	of	the	adapted	DCS	by	group	
	
0
20
40
60
80
0 5 10 0 5 10
booklet alone film + booklet
Fr
eq
ue
nc
y
In clinic adapted DCS score (out of 9)
